The management of blood cancer does not rely solely on advanced facilities, but also on the accuracy of medical procedures and close collaboration among experienced multidisciplinary teams. From Hodgkin and Non-Hodgkin lymphoma to multiple myeloma and leukemia, each type of blood cancer requires a standardized and well-coordinated therapeutic approach.
To address these challenges, Mandaya Royal Hospital Puri established the Mandaya Blood Cancer Center, implementing clinical protocols that refer to world-class cancer referral hospitals. Furthermore, the Mandaya Cancer Center collaborates with the National University Hospital (NUH) Singapore to deliver blood cancer treatment that meets international standards.
Contents
Leading Facilities and Services at the Mandaya Blood Cancer Center
The Mandaya Blood Cancer Center is supported by comprehensive medical facilities and advanced technology to optimize diagnosis, treatment, and patient monitoring. Key services include:
1. Hematopoietic Stem Cell Transplant (HSCT)
HSCT is one of the core services at the Mandaya Blood Cancer Center. This procedure aims to replace bone marrow damaged by blood cancer with healthy blood-forming stem cells. Through HSCT, normal blood cell production can be restored, helping to improve patients’ quality of life.
2. ICIR/PICIR (Immunocompromised Room)
To support the success of HSCT, Mandaya Royal Hospital Puri provides ICIR/PICIR facilities—specialized treatment rooms for patients with weakened immune systems following transplantation. These rooms are designed as part of the HSCT care ecosystem to reduce the risk of infection during the recovery period.
3. Irradiated Blood Transfusion
Irradiated blood transfusion services are also available to prevent serious complications such as Transfusion-Associated Graft-Versus-Host Disease (TA-GvHD), particularly in blood cancer patients who have undergone stem cell transplantation.
4. Comprehensive Systemic Therapy
The Mandaya Blood Cancer Center offers a full range of systemic therapies, including chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Each treatment plan is carefully tailored to the type of blood cancer and the patient’s clinical condition.
5. Digital PET/CT Scan
For diagnostic evaluation and treatment monitoring, Digital PET/CT Scan technology is utilized to visualize the location, metabolic activity, and spread of cancer cells in a detailed and accurate manner, assisting physicians in determining the most appropriate treatment strategy.
6. Flow Cytometry Examination
Advanced laboratory tests such as flow cytometry are performed to analyze the characteristics of blood cancer cells and to assess patient response to ongoing therapy.
7. Apheresis Services
As part of comprehensive care, Mandaya Royal Hospital Puri provides apheresis procedures to reduce abnormal blood components, such as excessive white blood cells in leukemia patients. This procedure also allows blood components to be adjusted according to patient needs, enabling faster symptom control.
KHOM Specialist Team at the Mandaya Blood Cancer Center
Medical Hematology-Oncology consultants (KHOM) are internal medicine subspecialists with expertise in diagnosing and treating various blood disorders, including blood cancer. Mandaya Royal Hospital Puri is supported by five experienced KHOM specialists who are ready to manage lymphoma, leukemia, and multiple myeloma.
1. dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM
An internal medicine specialist with a subspecialty in Medical Hematology-Oncology, dr. Toman graduated from the Faculty of Medicine, University of Indonesia, and completed his specialist training at Cipto Mangunkusumo Hospital. He also participated in an Honorary Fellowship at the Department of Hematology, National University Hospital (NUH) Singapore.
His expertise includes chemotherapy, immunotherapy, targeted therapy, and apheresis procedures.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. dr. Alvin Tagor Harahap, Sp.PD-KHOM
A graduate of the Faculty of Medicine, University of Indonesia, dr. Alvin has strong competence in managing blood cancer and hematologic disorders. His services include chemotherapy, immunotherapy, targeted therapy, and apheresis, delivered through a comprehensive medical approach.
Practice schedule at Mandaya Royal Hospital Puri:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
One of Indonesia’s leading hematology-oncology experts, Prof. Aru has made significant contributions to the development of national cancer services. His expertise spans chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy.
Practice schedule at Mandaya Royal Hospital Puri:
-
Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
A consultant in Medical Hematology-Oncology with extensive experience in treating blood cancer and hematologic disorders, Dr. Andree applies a personalized, patient-centered therapeutic approach based on individual clinical needs.
Practice schedule at Mandaya Royal Hospital Puri:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K)
dr. Nia focuses on the management of blood cancer and complex hematologic disorders, with expertise in chemotherapy, immunotherapy, and targeted therapy based on the latest medical advancements.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Mandaya–NUH Singapore Collaboration for More Precise Blood Cancer Therapy
The Mandaya Blood Cancer Center at Mandaya Royal Hospital Puri has established a close collaboration with NCIS–NUH Singapore through cross-border multidisciplinary case discussions. Each patient is jointly evaluated by expert teams from Mandaya and NUH Singapore to ensure diagnostic accuracy, treatment effectiveness, and the selection of the most appropriate therapy based on individual conditions.
This collaboration also provides patients with direct access to international second opinions from experienced blood cancer specialists. Erwin Suyanto, Public Relations Manager of Mandaya Hospital Group, stated that the establishment of the Mandaya Blood Cancer Center reflects Mandaya Royal Hospital Puri’s commitment to delivering comprehensive cancer services that are fully integrated with leading global cancer centers.
With complete facilities and strategic collaboration with NCIS–NUH Singapore, Mandaya Royal Hospital Puri continues to strengthen its position as an international-standard blood cancer referral hospital in Indonesia.
To make your visit to Mandaya Royal Hospital Puri more convenient, you can use the Chat via WhatsApp feature, Book Appointment service, or the Care Dokter application, available for download on Google Play and the App Store, to simplify visits, check queue numbers, and access complete information.
